Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT)
    Meeting Abstract

    Varghese, A. M.; Ang, C.; Dimaio, C. J.; Javle, M. M.; Gutierrez, M.; Yarom, N.; Stemmer, S. M.; Golan, T.; Geva, R.; Semenisty, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)
    Meeting Abstract

    Schwartz, L. H.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase III study of first-line zolbetuximab plus CAPOX versus placebo plus CAPOX in Claudin 18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: GLOW
    Meeting Abstract

    Shah, M. A.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shitara, K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A. M.; Drilon, A. E.; Macarulla, T.; O'Reilly, E. M.; Rodon, J.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C.; Lam, J. Y. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2-positive metastatic pancreatic cancer (mPC)
    Meeting Abstract

    Park, W.; O'Reilly, E. M.; Furuse, J.; Kunieda, F.; Jie, F.; Kindler, H. L.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Error-free, automated data integration of exosome cargo protein data with extensive clinical data in an ongoing, multi-omic translational research study
    Meeting Abstract

    Oromendia, A.; Ismailgeci, D.; Ciofii, M.; Donnelly, T.; Bojmar, L.; Jyazbek, J.; Chatterjee, A.; Lyden, D.; Yu, K. H.; Kelsen, D. P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05
    Meeting Abstract

    Moffat, G. T.; Watson, D.; Kapoor, S.; Roy, K. G. G.; Parashar, R.; Alam, A.; Alam, A.; Tyagi, A.; Singh, D.; Kumari, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Rural and urban disparities based on zip code of residence: Analyses of 834 and 2,159 patients in NCCTG N9741 and CALGB 80405 (Alliance) trials respectively
    Meeting Abstract

    Malla, M.; Huebner, L. J.; Piawah, S.; Lenz, H. J.; Blanke, C. D.; Meyerhardt, J. A.; O'Reilly, E. M.; Shi, Q.; Venook, A. P.; Goldberg, R. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Do differences in the microbiome explain early onset in colon cancer?
    Meeting Abstract

    Keshinro, A.; Vanderbilt, C.; Stadler, Z. K.; Shia, J.; Gonen, M.; Chen, C. T.; Cercek, A.; Mendelsohn, R. B.; Yaeger, R.; Zehir, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Actionable alterations (AA) in gastrointestinal (GI) cancers: Rate of detection and receipt of matched therapies (MT)
    Meeting Abstract

    Greally, M.; Tuvy, Y.; Millang, B. M.; O'Reilly, E. M.; Yaeger, R.; Saltz, L. B.; Ku, G. Y.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save